Computer generated transcript

Warning!
The following transcript was generated automatically from the content and has not been checked or corrected manually.

um, I'd like to invite a jillion Bubka's well into the siege to take any question from the floor. If I don't, you would be happy to do that. Well, it's Come on. So quick. Question. Just about the kind of last point you were mentioning about industry responding to kind of pressure coming from us because obviously not something we can do. You know, as with pedic surgeons and hopefully with the consultants in the future, have you seen many kind of groups of or three excited or surgeon general kind of funding together to push for change either in the UK or over in the US? And you know how they got about that? Yeah, that's a great question. As far as from the state of really aspect. Um, sadly, it's, um, not something that I've seen a ton of just yet in the US. Um, but I have seen it from just the product perspective. Um, I like I said I worked for arthritis. They're very responsive company. And, um, they did have ah, really good year to listen to what the surgeons were actually saying and giving them in the field. And so I do really believe that, um, as we kind of moved to these I mentioned intratesticular. Okay, I didn't really dive into them much. But their whole model in the whole vision for the future is is building systems where you can actually, um, create smaller units of product meaning instead of having to produce a million at a time, they can produce 5000 to 10,000 at a time, which is a huge change. And I think as industry continues to move that way, and I think his conditions put that pressure on them to move that way, ultimately, they're gonna have to get creative and find ways to work with them. Um, and not against them, because ah, it it it is the truth. I mean, industry is truly trying to gain more access. So a slow is the voices are collecting and moving them. They will move with them. So is what I've seen multiple times. Great. Thanks very much. That Gillian, we had a question in the chapped from Donna. More asking. Have you looked to any other gas? I think it's got a volatile capture technology. And you told me Well, is year so? Well, there are two companies that I'm aware of, which the ones I mentioned. So this stage tech, which is a British company, they're based down in Devon, um, and then Baxter, based in Germany. On that, both adds, a Baxter is more established at the moment. It's being used more widely because they've already got a system in place where a stage tack is. I mean, essentially, it was a startup company, and it's just done really well. They've been piloting their product in various hospitals, in different parts of the UK, particularly down and definite calmer, but also up in Newcastle on I think they are looking to start actually selling their technology to hospital. So I think they are the only ones I'm aware ALS on. But I could be wrong about that. Thank you. And another question kind of really assumes for either or both of you. Alex, we we've spoken a little bit about a push from asses surgeons, you know, to more kind of sustainable technology. Gillian, do you foresee or do you know anything about anything similar kind of going on from within our set? It's I know you guys have formed gas, which is incredible. but all the pushes from within our septic system of fun together and say No, we don't want, you know, we don't want to use your stuff if you're not going to make it green. Yeah, absolutely, I think from the gas perspective. Absolutely. So I'd say there's a There's a massive push to get rid of desperation entirely, so that stops the first thing on. I think there's been some decent evidence to say that there isn't really a good clinical indication to keep using it on the indications that were cited previously. So things like neurosurgery, bariatric surgery. Actually, the evidence isn't good enough to say that they're worth using. So I was at our Syria conference a few weeks ago on there was loads of discussion about it, and it was just a sort of clear message that were ditching it, and it's going to go, so that's really good, because that's coming from a sort of a college level on. But I think everybody is aware of the issues with nitrous that's a little more complex because it is outside of our remit. I mean, it's within a remember if it's within other people's remain as well, so emergency medicine and maternity, but again that there has been really good pushes on. There was some really good work presented actually from from Cardiff. I believe in any cyst there who has done a really good sort of nitrous reduction project. So that's really good. And in terms of, like, single news items, that sort of thing. Yes, I would say it's less offer. Push it the moment cause I think grasses of the low hanging fruit. At the moment, they're the other thing that we we have more control over whether we use or no on. But my own trust had a talk from somebody who was selling single use bronchoscopes on day was a lot of angry chatter in the sort of chap box saying, Why? Why are we having somebody selling single use bronchoscope like what we're doing? So I think I think it's the message is getting through. But it does take a bit of time for people to get on board. Yeah, absolutely. I think there's a there's a big push from, as you say, the people who are making single you stuff to perpetuate this myth. That single use is is the cleanest and the best we're going to get. I think some of the stuff you mentioned, Alex about different ways of getting ready, for example, the Blue rock, you know, and ways around because obviously that's something we use, you know, hundreds and hundreds of tons over a year, you know, wrapping all of our stuff. And then half the time we find holes in it and, you know, send a K off. Anyway, um, we've had a comment in chapped from Cyrus. A funky sira are amazing. I said excema Oxford is sure we can safely, um, it group and save testing an emergency appendicectomy. And they're pushing for our surgical teams to review on. I think that's something really important that we can all look up. Isn't it across? You know, there are, you know, from our point of view, lots of procedures that we, you know, we need groups and saved across much is for but reducing unnecessary testing. I know that was, um was it the Green Ward Challenge? I think in emergency department 11 of the green Ward challenges by reducing the number of unnecessary blood test they were doing. I think that's that's gonna be really important going forward. And I wonder. Come about to your previous point, Gillian. Whether kind of with regards to stuff like nitrous, which is obviously actually under the remainder of so many different specialties know we in orthopedics use it quite a lot, as you say, you know, for a juice enjoying, you know, doing the NEBs, all of that sort stuff, obviously maternity big users in motion department, big users. You know, maybe we'll need to balance together, you know, and take out like that idea on and just, you know, kind of work not just in silos with their own specialties, but across specialties to kind of make the difference. They know we knew. You know, we we want better way to this, or if you want us to buy it, we want you to do it better. Yeah, it's It's definitely got to be a multi disciplinary kind of team approach. You've got to get from attorney in particular. You've got to get the sort of lead midwives on board. It's got to be clear that it's know about taking away analgesia. Cop shins. For women in labor, it is about disposing of the gas responsibly. I think that's quite a lot of understandable concerns about, I think sometimes it's interpreted with reducing Nitrous is interpreted as no pain relief for women who are in labor on it's really not that at all. And I'm quite like to dispel that because it frustrates me a little bit because actually, the capture technology means that we could keep using it. It just means it's not gonna be doing the home that it was doing before on. But it's not taking away and anagesic option. But that's sometimes how it's been interpreted. It can be a bit of a challenge with communication, particularly to the media, on to the wider public why this is important and why it's not going to impact on patient care, making these environmental changes that such gonna make it better and going back to what you said about packaging. There is some really good sort of. I love the term low hanging fruit, but there are some really good options on, but recently in our region, we have been auditing the contents of our central line packs on arterial line packs on. Basically, people are saying what they're not using from the park because it's just a generic Packers been. They've been told what to put in the pack by a certain group of people 10 years ago, but actually, some of it's not relevant anymore. So even just really small changes, even taking out the drawing up needle or that sort of thing, it reduces the Sharps waste. So there's there's loads of little projects that could be that could be done. And you can make quite a big impact with just small things as well. Yeah, absolutely. And I think that's that's something I thought about several times kind of animal with the pediarix. You know, the amount of stuff we open, you know, and how much of it do we actually need and use? And actually, if there were ways to, you know, sterilized and wrap stuff as Alex was suggesting that don't you know we don't necessarily need you to put everything into 57 different individually wrapped bits if we're not going to use it? But actually, if there's ways to minimize the kit we use as a process, that decision was saying, you know we can then, you know, probably reduce the carbon footprint of what we're doing, you know, by a significant amount by just just like, as you say, just taking out what we do use it when I think I think two never, like just one last point on that, too. On the voice to you, I think Just never underestimate how powerful your voice really is. This as a physician and the clinician and and how how responsive these companies will become as more and more people kind of collect. And I think it does kind of start with those little minor changes changes making yourself kind of the advocate within your certain trust. Um, and in those little kind of first initial steps, then kind of labels you in the industry of such. And you have a different platform within the industry itself, too. I think it really Yeah. Don't underestimate how powerful your voice really is, is all I would say to that because industry will respond, even though they seem like giants. And they won't. They will. So brilliant. Thank you so much. Have we got any more questions from the floor? Um, at the moment doesn't look like it. So we're going to go to another quick coffee break. Just until about court past four, if that's okay with people. Alex. Gillian, thank you. So so much for coming to our conference and given as your opinions and I think really starting a lot of ideas about you know what we can do. As you say, Alex, you know how we can use our voices for good and kind of. I think sometimes we feel like, you know, we just do it were told, but actually, you know, I think you're right. We can We can push the change from within within the NHS, always within the private sector or whatever. People are working, you know, we can bump together and really, really push. We're good. So thank you ever so much. Guys. Remember the on the sessions tab? There is a room in a Congrats on and have a chart and discuss ideas if you like. Um, if anyone was to use that during the break, you are more than welcome. And we'll see you back again at court past